FDA approves new Dupixent® (dupilumab) pre-filled pen ... - Sanofi
WEBJun 19, 2020 · The pre-filled pen features a hidden needle and single-press auto-injection, along with visual and audio feedback to help with administration. Regeneron and Sanofi are working with the FDA to provide additional data they require to complete their review of the 200 mg pre-filled pen.
DUPIXENT® (dupilumab) Injection Instructions & Support
WEBFind videos and downloadable instructions for the two injection administration options available for DUPIXENT® (dupilumab), pre-filled syringe (200 mg or 300 mg) with needle shield for ages 6 months & older, or pre-filled pen (200 mg or 300 mg) for ages 2+ years. DUPIXENT® is a prescription medicine FDA-approved to treat six conditions.
US FDA approves the Cyltezo® Pen, a new autoinjector option, …
WEBRIDGEFIELD, Conn., May 22, 2023 /PRNewswire/ -- Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) has approved the Cyltezo ® Pen, a new autoinjector option...
Press Room - Sanofi US News
WEBOct 20, 2023 · Dupilumab is being jointly developed by Sanofi and Regeneron under a global collaboration agreement. To date, dupilumab has been studied across more than 60 clinical trials involving more than 10,000 patients with various chronic diseases driven in part by type 2 inflammation.
AutoPen - Owen Mumford
WEBAutopen ® is compatible with all major brands of pen needle and comes in two models, Autopen ® 24 for use with SANOFI insulin cartridges and Autopen ® Classic for use with Lilly¹ and Wockhardt insulin cartridges.
Sanofi’s talking allergy device an answer to Dey’s EpiPen
WEBAug 14, 2012 · The drugmaker's new auto-injecting epinephrine pen provides verbal cues during emergency allergic situations. It's the latest entry in a competitive market. The first-line defense against anaphylactic shock is an epinephrine injection, and …
AUVI-Q® (epinephrine injection, USP) for Anaphylaxis
WEBMeet AUVI‑Q, the voice-guided epinephrine auto-injector that can tell you, or those caring for your child, how to help in an allergic emergency. Get the Severe Allergy Toolkit. Patient portrayal. We’re there when you need us. Once you have a prescription, AUVI‑Q is as easy to get as it is to use. It can even be delivered right to your front door.
Press Room - Sanofi US News
WEBSanofi Announces FDA Approval for Auvi-Q™, First Voice-guided Epinephrine Auto-injector for Patients with Life-threatening Allergies -- Breakthrough device design talks patients and caregivers through the injection process --
Auvi-Q Auto-Injector: Side Effects, Dosage & Uses - Drugs.com
WEBOct 9, 2023 · Auvi-Q (epinephrine auto-injector) is a voice-guided epinephrine injection used to treat life-threatening allergic reactions. Includes Auvi-Q side effects, interactions and instructions for use.
Sanofi Announces Auvi-Q™, the First and Only Voice-Guided …
WEBJan 28, 2013 · Auvi-Q is the first-and-only epinephrine auto-injector with audio and visual cues for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a...